Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease.

about

Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease.

Item

http://www.wikidata.org/entity/Q38782413

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Epidemiology and Risk Factors ...... th Inflammatory Bowel Disease.

@en

type

Item

label

Epidemiology and Risk Factors ...... th Inflammatory Bowel Disease.

@en

prefLabel

Epidemiology and Risk Factors ...... th Inflammatory Bowel Disease.

@en

P1476

Epidemiology and Risk Factors ...... th Inflammatory Bowel Disease.

@en

P2093

Bincy P Abraham

http://www.w3.org/2001/XMLSchema#string

Hoda M Malaty

http://www.w3.org/2001/XMLSchema#string

Kerri Glassner

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis

Role of the intestinal microbiome in liver disease.

Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-a case series and review of the literature

Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

Gastrointestinal and liver adverse effects of drugs used for treating IBD.

P304

998-1003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MIB.0000000000001085

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28511199

http://www.w3.org/2001/XMLSchema#string